proline and Nasopharyngeal Neoplasms

proline has been researched along with Nasopharyngeal Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daoud, J; Frikha, M; Gargouri, A; Ghorbel, A; Hadhri-Guiga, B; Khabir, A; Mokdad-Gargouri, R; Sellami-Boudawara, T; Toumi, N1
Bulay, O; Mirvish, SS; Patil, K; Runge, RG1
Chang, FC; Chen, WC; Hsieh, YY; Lin, CD; Tsai, CH; Tsai, FJ; Tsai, MH1

Other Studies

3 other study(ies) available for proline and Nasopharyngeal Neoplasms

ArticleYear
Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Cancer genetics and cytogenetics, 2007, Oct-15, Volume: 178, Issue:2

    Topics: Adolescent; Adult; Aged; Apoptosis; Carcinoma; Carcinoma, Squamous Cell; Child; Codon; Humans; Middle Aged; Nasopharyngeal Neoplasms; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proline; Reference Values; Tumor Suppressor Protein p53; Tunisia

2007
Study of the carcinogenicity of large doses of dimethylnitramine, N-nitroso-L-proline, and sodium nitrite administered in drinking water to rats.
    Journal of the National Cancer Institute, 1980, Volume: 64, Issue:6

    Topics: Animals; Body Weight; Carcinogens; Dimethylamines; Dose-Response Relationship, Drug; Female; Lethal Dose 50; Liver Neoplasms; Male; Nasopharyngeal Neoplasms; Neoplasms, Experimental; Nitrites; Nitro Compounds; Nitrosamines; Proline; Rats; Stomach Neoplasms

1980
Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma.
    The Laryngoscope, 2002, Volume: 112, Issue:1

    Topics: Arginine; Cell Division; Cell Transformation, Neoplastic; China; Chromosomes, Human, Pair 17; Codon; Heterozygote; Homozygote; Humans; Mutation; Nasopharyngeal Neoplasms; Neoplasm Staging; Polymorphism, Genetic; Prognosis; Proline; Tumor Suppressor Protein p53

2002